Legal Representation
Attorney
Eric Lamb
USPTO Deadlines
Next Deadline
9 days remaining
Examiner's Amendment Completed
Due Date
July 29, 2025
Application History
22 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 14, 2025 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
Jul 14, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jul 14, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jul 14, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jul 14, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 27, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 26, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jun 26, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 15, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Apr 15, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Apr 15, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Apr 15, 2025 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
Apr 11, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
Apr 11, 2025 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
Apr 11, 2025 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
Apr 11, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 11, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Mar 11, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 11, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 4, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 28, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 28, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Stem cell therapy services; Medical testing for diagnostic or treatment purposes; Healthcare and medical tourism services, namely, establishing and maintaining healthcare provider facilities in other countries for the provision of healthcare services; Medical clinic providing hormone therapy, including, bioidentical hormone replacement, human growth hormone therapy, and natural hormone therapy; Consulting services in the field of hormone replacement therapy; Regenerative medicine services; Medical imaging services; Skin treatment, namely, the injection of dermal fillers to reduce the appearance of facial lines and wrinkles; Injectable botulinum toxin treatment services for medical purposes; Injectable botulinum toxin treatment services for cosmetic purposes; Providing laser therapy for treating medical conditions
First Use Anywhere:
Jan 27, 2025
First Use in Commerce:
Jan 27, 2025
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICAL INSTITUTE"